Drug Trial Radar · NCT00320619
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
Last checked: Nov 20, 2026Latest source record: Jul 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182
Actual
Start
Sep 2000
Primary completion
Feb 2006
Study completion Feb 2006
Sponsor
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)NIH
- Sponsor type
- NIH
- First posted
- May 3, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Individuals who undergo spine surgery often have a significant loss of blood and may require multiple blood transfusions. Research has shown that epsilon-aminocaproic acid (EACA) may reduce the amount of blood lost during surgery, which would decrease the number of blood transfusions required. This study will evaluate the safety and effectiveness of EACA at reducing blood loss and the need for blood transfusions in individuals undergoing spine surgery.
Conditions
- Scoliosis
- Kyphosis
- Lordosis
- Spondylitis
- Spinal Stenosis
Interventions
Epsilon-Aminocaproic Acid (EACA)Drug
Participants will receive EACA intravenously during surgery and for 8 hours following surgery in the intensive care unit (ICU).
PlaceboDrug
Participants will receive placebo intravenously during surgery and for 8 hours following surgery in the intensive care unit (ICU).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of allogenic blood units transfusedTime frame: Measured through the 8th postoperative day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Johns Hopkins Hospital
Baltimore, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.